Suppliers / Dzd (Heze) Pharmaceutical

Dzd (Heze) Pharmaceutical

China Updated 9 July 2026

Dzd (Heze) Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 3 valid CEPs across a filed portfolio of 4 molecules. Its GMP standing is certified by EMA.

4
active US DMFs
3
valid CEPs
3
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Heze City, China Not on file
Heze, China Not on file
China, China 3012104330

What they file, and where

Molecule Regulators Docs
Doxorubicin EDQM, SFDA (Saudi Arabia), US FDA 3
Daunorubicin EDQM, US FDA 2
Epirubicin EDQM, US FDA 2
Valrubicin US FDA 1

Also appears on these molecule pages

Daunorubicin API Doxorubicin API Epirubicin API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Dzd (Heze) Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates